CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- 4 Option exercise VP, CFO AND SECRETARY acquired 89,742 shares (option exercise)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
- 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 3,391 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 5,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
- 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 6 of 15 · 282 filings